These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17917070)

  • 1. Strategies for differentiating embryonic stem cells (ESC) into insulin-producing cells and development of non-invasive imaging techniques using bioluminescence.
    Chan KM; Raikwar SP; Zavazava N
    Immunol Res; 2007; 39(1-3):261-70. PubMed ID: 17917070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous in vivo differentiation of embryonic stem cell-derived pancreatic endoderm-like cells corrects hyperglycemia in diabetic mice.
    Raikwar SP; Zavazava N
    Transplantation; 2011 Jan; 91(1):11-20. PubMed ID: 21452407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-culture with mature islet cells augments the differentiation of insulin-producing cells from pluripotent stem cells.
    Oh BJ; Oh SH; Choi JM; Jin SM; Shim WY; Lee MS; Lee MK; Kim KW; Kim JH
    Stem Cell Rev Rep; 2015 Feb; 11(1):62-74. PubMed ID: 25173880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation and lineage commitment of murine embryonic stem cells into insulin producing cells.
    Raikwar SP; Zavazava N
    Methods Mol Biol; 2013; 1029():93-108. PubMed ID: 23756944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-producing cells derived from human embryonic stem cells: comparison of definitive endoderm- and nestin-positive progenitor-based differentiation strategies.
    Wei R; Yang J; Hou W; Liu G; Gao M; Zhang L; Wang H; Mao G; Gao H; Chen G; Hong T
    PLoS One; 2013; 8(8):e72513. PubMed ID: 23951327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [From stem cells to functional beta cells in type 1 diabetes].
    Engberg N; Hansson M; Madsen OD
    Ugeskr Laeger; 2010 Sep; 172(38):2608-12. PubMed ID: 20920405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definitive endoderm: a key step in coaxing human embryonic stem cells into transplantable beta-cells.
    Semb H
    Biochem Soc Trans; 2008 Jun; 36(Pt 3):272-5. PubMed ID: 18481940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Building better beta cells.
    Stanley EG; Elefanty AG
    Cell Stem Cell; 2008 Apr; 2(4):300-1. PubMed ID: 18397747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin producing cells derived from embryonic stem cells: are we there yet?
    Raikwar SP; Zavazava N
    J Cell Physiol; 2009 Feb; 218(2):256-63. PubMed ID: 18932230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo.
    Kroon E; Martinson LA; Kadoya K; Bang AG; Kelly OG; Eliazer S; Young H; Richardson M; Smart NG; Cunningham J; Agulnick AD; D'Amour KA; Carpenter MK; Baetge EE
    Nat Biotechnol; 2008 Apr; 26(4):443-52. PubMed ID: 18288110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enrichment of human embryonic stem cell-derived NKX6.1-expressing pancreatic progenitor cells accelerates the maturation of insulin-secreting cells in vivo.
    Rezania A; Bruin JE; Xu J; Narayan K; Fox JK; O'Neil JJ; Kieffer TJ
    Stem Cells; 2013 Nov; 31(11):2432-42. PubMed ID: 23897760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human embryonic stem cell differentiation into insulin secreting β-cells for diabetes.
    Bose B; Shenoy SP; Konda S; Wangikar P
    Cell Biol Int; 2012 Nov; 36(11):1013-20. PubMed ID: 22897387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generating insulin-producing cells for diabetic therapy: existing strategies and new development.
    Shen J; Cheng Y; Han Q; Mu Y; Han W
    Ageing Res Rev; 2013 Mar; 12(2):469-78. PubMed ID: 23318683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to make insulin-producing pancreatic β cells for diabetes treatment.
    Lu J; Xia Q; Zhou Q
    Sci China Life Sci; 2017 Mar; 60(3):239-248. PubMed ID: 27796637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro generation of pancreatic β-cells for diabetes treatment. I. β-like cells derived from human pluripotent stem cells.
    Cierpka-Kmiec K; Wronska A; Kmiec Z
    Folia Histochem Cytobiol; 2019; 57(1):1-14. PubMed ID: 30869153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-cell replacement for insulin-dependent diabetes mellitus.
    Efrat S
    Adv Drug Deliv Rev; 2008 Jan; 60(2):114-23. PubMed ID: 18022276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vitro Differentiation of Pluripotent Stem Cells into Functional β Islets Under 2D and 3D Culture Conditions and In Vivo Preclinical Validation of 3D Islets.
    Bose B; Sudheer PS
    Methods Mol Biol; 2016; 1341():257-84. PubMed ID: 25783769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of insulin-producing cells from primitive biologic precursors.
    Evans-Molina C; Vestermark GL; Mirmira RG
    Curr Opin Organ Transplant; 2009 Feb; 14(1):56-63. PubMed ID: 19337148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generating pancreatic beta-cells from embryonic stem cells by manipulating signaling pathways.
    Champeris Tsaniras S; Jones PM
    J Endocrinol; 2010 Jul; 206(1):13-26. PubMed ID: 20385725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regenerative medicine for diabetes: differentiation of human pluripotent stem cells into functional β-cells in vitro and their proposed journey to clinical translation.
    Bose B; Katikireddy KR; Shenoy PS
    Vitam Horm; 2014; 95():223-48. PubMed ID: 24559920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.